Cite
HARVARD Citation
Sands, B. et al. (n.d.). DOP054 Vedolizumab in combination with steroids for induction therapy in Crohn's disease: an exploratory analysis of the GEMINI 2 and GEMINI 3 studies. Journal of Crohn's and colitis. p. S068. [Online].